TMEM191A: A Protein Involved in Brain Function and Potential Drug Targets

Target Name: TMEM191A

NCBI ID: G84222

TMEM191A

Other Name(s): TMEM191AP | transmembrane protein 191A (pseudogene) | Transmembrane protein 191A (pseudogene)

TMEM191A: A Protein Involved in Brain Function and Potential Drug Targets

TMEM191A is a protein that is expressed in various tissues throughout the body, including the brain, heart, and kidneys. It is a member of the transmembrane protein family, which means that it spans the cell membrane and extends into the cytoplasm. TMEM191A is involved in a number of cellular processes that are important for normal brain function, including the regulation of ion channels, the transport of nutrients and waste products, and the maintenance of cell shape.

One of the unique features of TMEM191A is its ability to form a homodimeric complex with itself. This means that two copies of the same TMEM191A protein can come together and form a single protein that is both catalytic and sensitive to changes in its environment. This structural feature allows TMEM191A to function as a protein that can be regulated both by its own protein interactions and by those of its interactions with other proteins.

In addition to its structural features, TMEM191A is also known for its role in a number of cellular processes that are important for brain development and function. For example, TMEM191A has been shown to be involved in the regulation of the neurotransmitter synapse, which is the structure where neurotransmitters (such as dopamine and GABA) are released and received from neurons. This is important for the development and maintenance of normal brain function, as well as for the treatment of neuropsychiatric disorders.

Another key role for TMEM191A is in the regulation of ion channels, which are responsible for the flow of electrical current through the cell membrane. The ability of TMEM191A to form a homodimeric complex allows it to regulate ion channels in a dynamic and flexible manner, which is important for the regulation of a wide range of physiological processes, including muscle contractions, nerve impulses, and the regulation of blood pressure.

In addition to its roles in the regulation of ion channels and the neurotransmitter synapse, TMEM191A is also involved in the regulation of cell shape and the transport of nutrients and waste products. For example, TMEM191A has been shown to be involved in the regulation of the cytoskeleton, which is the structure that gives cells shape and provides support. This is important for the proper functioning of cells, including the regulation of cell division and the maintenance of cell shape.

TMEM191A is also involved in the regulation of cell signaling pathways, which are the processes by which cells communicate with one another and with their environment. This is important for the regulation of a wide range of physiological processes, including growth, development, and response to stimuli.

In conclusion, TMEM191A is a protein that is involved in a wide range of cellular processes that are important for normal brain function. Its ability to form a homodimeric complex and its involvement in the regulation of ion channels, the neurotransmitter synapse, cell shape, and cell signaling pathways make it an attractive drug target and a potential biomarker for a variety of neuropsychiatric disorders. Further research is needed to fully understand the role of TMEM191A in brain function and its potential as a drug target.

Protein Name: Transmembrane Protein 191A (pseudogene)

The "TMEM191A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM191A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets